BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2025 Earnings Call Transcript October 27, 2025
BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $-1.09923 EPS, expectations were $0.01.
Operator: Hello, and welcome to the BioMarin Pharmaceutical Third Quarter 2025 Conference Call. [Operator Instructions]. I would now like to turn the conference over to Traci McCarty. Please go ahead.
Traci McCarty: Thank you, operator. To remind you, this nonconfidential presentation...
